WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Comparison of Body Composition & Weight Change in Users of Progestin-only Contraception During the First Year of Use
Completed
- Conditions
- Weight Change
- First Posted Date
- 2012-04-18
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 345
- Registration Number
- NCT01579773
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Buprenorphine Disposition and CYP3A
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2012-04-12
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 21
- Registration Number
- NCT01576575
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Cognitive Changes in Adult Cancer Survivors
Completed
- Conditions
- Effects of ChemotherapyCognitive Impairment
- First Posted Date
- 2012-04-03
- Last Posted Date
- 2013-02-26
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT01569932
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Healthy Eating and Active Living Taught at Home
Not Applicable
Completed
- Conditions
- ObesityDiabetes
- Interventions
- Behavioral: PAT Curriculum + Health Information
- First Posted Date
- 2012-03-30
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 460
- Registration Number
- NCT01567033
- Locations
- πΊπΈ
Washington University, Saint Louis, Missouri, United States
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
Phase 2
Completed
- Conditions
- Head and Neck Neoplasms
- Interventions
- Radiation: Intensity modulated radiation therapyProcedure: Quality-of-life assessment
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT01566435
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Sodium Management in Acute Neurological Injury
Completed
- Conditions
- This Study is to Understand the Current Practice of Sodium Management in Acute Neurological Injury
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2019-05-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 400
- Registration Number
- NCT01558843
- Locations
- πΊπΈ
Columbia University, New York, New York, United States
πΊπΈUK Healthcare, Lexington, Kentucky, United States
πΊπΈMemorial University Medical Center, Savannah, Georgia, United States
Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer
Phase 2
Withdrawn
- Conditions
- Breast Neoplasms
- Interventions
- Biological: trastuzumab
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2013-07-04
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT01557764
Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT01555853
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
πΊπΈSt. Louis University School of Medicine, St. Louis, Missouri, United States
Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
Phase 2
Completed
- Conditions
- Thrombotic Thrombocytopenic Purpura
- Interventions
- Biological: rituximab
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT01554514
- Locations
- πΊπΈ
Emory University, Atlanta, Georgia, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
πΊπΈWashington University, Saint Louis, Missouri, United States
Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit
Not Applicable
Completed
- Conditions
- Pneumonia, Bacterial
- Interventions
- Other: 5 Days of AntibioticsOther: 7 Days of Antibiotics therapy for pneumonia
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 46
- Registration Number
- NCT01554657
Β© Copyright 2025. All Rights Reserved by MedPath